Sign in to continue:

Saturday, March 7th, 2026

Addentax Group Corp. and Guang Wen Global Limited Finalize Stock Purchase Agreement – Full Details, Terms, and Signatories

KEEMO Fashion Group Ltd Announces Correction to 8-K Filing and Details of Major Change in Control

Key Highlights

  • Amendment Filed: KEEMO Fashion Group Ltd (KMFG) filed an amended Form 8-K/A to correct a technical error in its previous report.
  • Change of Control: A change of control transaction has resulted in a new controlling shareholder holding approximately 62.18% of the company’s voting rights on a fully diluted basis.
  • Stock Purchase and Bond Transfer Agreements: The change of control was implemented via a Stock Purchase Agreement and a Bond Transfer Agreement, both of which are attached as exhibits to the filing.
  • OTC Markets Status: Company confirms compliance with OTC Markets requirements and states it is not a “shell company.”

Detailed Article

KEEMO Fashion Group Ltd (“KEEMO” or the “Company”) has announced an amendment to its previously filed 8-K report, correcting the item number initially tagged in its submission. The correction clarifies that the relevant disclosure should have been filed under Item 8.01 (Other Events), rather than Item 5.01. This clarification is crucial for regulatory compliance and transparency to shareholders.

Major Transaction and Change of Control

The most significant development disclosed in this filing is a change in the control of KEEMO Fashion Group Ltd. Through a combination of a Stock Purchase Agreement (dated February 17, 2026) and a Bond Transfer Agreement (dated February 18, 2026), a new purchaser has acquired a controlling interest in the Company. After the completion of these transactions, the purchaser now holds approximately 62.18% of the voting rights of KEEMO, making them the controlling shareholder.

The purchase was structured such that the buyer acquired shares and delivered a bond to the seller as consideration. The agreements specify that the shares transferred are free and clear of all encumbrances, liens, or claims, and there are no outstanding rights, options, or warrants that would dilute the purchaser’s new controlling position.

Details of the Transaction Agreements

  • Stock Purchase Agreement:

    • The seller (identified as GUANG WEN GLOBAL LIMITED) sold its shares to the buyer (ADDENTAX GROUP CORP.).
    • All shares are transferred free and clear of encumbrances.
    • The seller warrants no brokers, finders, or similar parties are entitled to any fees in connection with this transaction.
    • There are no outstanding options, warrants, convertible securities, or rights affecting the shares transferred.
  • Bond Transfer Agreement:

    • Completes the consideration for the purchase by transferring a bond to the seller or its designated counterparty.

Company Representations and Financials

  • The Company has delivered complete audited financial statements for the years ending July 31, 2023, 2024, and 2025. These statements are GAAP-compliant and indicate the company has operated in the ordinary course of business with no material adverse changes since the last balance sheet date.
  • There have been no undisclosed liabilities, and all due diligence materials, including corporate records and tax filings, have been provided to the buyer.
  • KEEMO is current with all required OTC Markets filings and confirms it is not a “shell company.” The company’s shares remain eligible for quotation on the OTCID Market under the symbol “KMFG.”
  • No related party transactions or undisclosed agreements that could affect governance or control of the company were reported.

Forward-Looking Statements and Caveats

The company includes a standard Safe Harbor statement, indicating that forward-looking statements—such as expectations regarding the benefits of this transaction—are subject to risks and uncertainties. Actual results may differ from those anticipated due to various risks detailed in the company’s SEC filings.

Investor Takeaways

  • This filing signals a MAJOR CHANGE IN CONTROL for KEEMO Fashion Group Ltd, with a new controlling shareholder now holding over 62% of the company’s voting rights. Such a dramatic shift in ownership structure is highly material and could significantly affect the company’s strategic direction, management, and future operations.
  • The company’s confirmation of compliance with OTC Markets and its statement that it is not a shell company are reassuring for investors concerned about regulatory risk and listing compliance.
  • Absence of outstanding options, warrants, or convertible securities assures shareholders that the new controlling interest will not be immediately diluted by previously undisclosed instruments.

Potential Price Sensitivity

A change of control of this magnitude is typically price sensitive and could significantly affect the market value of KEEMO’s shares. Investors should closely watch for further announcements regarding any changes in strategic direction, management, or business model that the new controlling shareholder might implement.


Disclaimer: This article is for informational purposes only and is not investment advice or a recommendation to buy or sell any security. Investors should perform their own due diligence and consult with a financial advisor before making investment decisions. Forward-looking statements are subject to risks and uncertainties as described in the company’s SEC filings.

View KEEMO Fashion Group Ltd Historical chart here



Invesco CurrencyShares® Japanese Yen Trust 2025 Annual Report: Business Overview, Risk Factors, Financial Statements, and Governance Information

Invesco CurrencyShares Japanese Yen Trust 2025 Annual Report: Key Insights for Investors Invesco CurrencyShares Japanese Yen Trust 2025 Annual Report: Key Insights for Investors Overview The Invesco CurrencyShares Japanese Yen Trust (the “Trust”) has...

Evercore Inc. 2025 Annual Report: Business Overview, Financials, Growth Strategies, and Regulatory Insights

Evercore Inc. 2025 Annual Report: Key Highlights and Shareholder Insights Evercore Inc. 2025 Annual Report: Key Highlights and Shareholder Insights Overview Evercore Inc., recognized as the leading independent investment banking firm globally by dollar...

Lexicon Pharmaceuticals 2025 Annual Report: Drug Pipeline, FDA Updates, Partnerships, and Financial Overview

Lexicon Pharmaceuticals, Inc. 2025 Annual Report: Key Investor Insights Lexicon Pharmaceuticals, Inc. 2025 Annual Report: Key Investor Insights Overview Lexicon Pharmaceuticals, Inc. (“Lexicon” or “the Company”) is a biopharmaceutical company focused on pioneering medicines...

   Ad